CVS Health Corporation (NYSE: CVS) stock closed at 80.05 per share at the end of the most recent trading day (a -1.84% change compared to the prior day closing price) with a volume of 11.32M shares and market capitalization of 105.39B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.

The one-year performance of CVS Health Corporation stock is 24.22%, while year-to-date (YTD) performance is 17.2%. CVS stock has a five-year performance of -17.79%. Its 52-week range is between 55.36 and 90.61, which gives CVS stock a 52-week price range ratio of 70.04%

CVS Health Corporation currently has a PE ratio of 14.70, a price-to-book (PB) ratio of 1.53, a price-to-sale (PS) ratio of 0.53, a price to cashflow ratio of 7.00, a PEG ratio of 2.32, a ROA of 3.21%, a ROC of 6.12% and a ROE of 10.88%. The company’s profit margin is 2.15%, its EBITDA margin is 6.40%, and its revenue ttm is $205.71 Billion , which makes it $156.24 revenue per share.

Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.07 for the next earnings report. CVS Health Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.59), with a target price of $95.73, which is +19.59% compared to the current price. The earnings rating for CVS Health Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CVS Health Corporation has a dividend yield of 2.43% with a dividend per share of $2.00 and a payout ratio of 36.00%.

CVS Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 7.92, ATR14 : 1.63, CCI20 : -58.70, Chaikin Money Flow : 0.09, MACD : -0.09, Money Flow Index : 41.75, ROC : 1.09, RSI : 44.05, STOCH (14,3) : 42.16, STOCH RSI : 0.00, UO : 53.24, Williams %R : -57.84), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan Lotvin (Option Excercise at a value of $1 716 346), Alan Lotvin (Sold 40 112 shares of value $2 937 020 ), Alan M. Lotvin (Option Excercise at a value of $3 432 692), Alan M. Lotvin (Sold 68 729 shares of value $5 107 406 ), Daniel P. Finke (Option Excercise at a value of $1 751 420), Daniel P. Finke (Sold 37 594 shares of value $3 255 640 ), Edward J. Ludwig (Buy at a value of $216 000), Eva C. Boratto (Option Excercise at a value of $1 402 743), Eva C. Boratto (Sold 23 787 shares of value $1 802 507 ), James D. Clark (Option Excercise at a value of $397 452), James D. Clark (Sold 5 350 shares of value $406 600 ), Jonathan C. Roberts (Option Excercise at a value of $5 455 337), Jonathan C. Roberts (Sold 73 433 shares of value $5 470 024 ), Joshua Flum (Option Excercise at a value of $750 242), Joshua Flum (Sold 21 460 shares of value $1 502 200 ), Larry J. Merlo (Option Excercise at a value of $49 877 858), Larry J. Merlo (Sold 667 086 shares of value $50 136 870 ), Lisa Bisaccia (Option Excercise at a value of $3 740 798), Lisa Bisaccia (Sold 50 354 shares of value $3 877 258 ), Thomas M. Moriarty (Option Excercise at a value of $13 024 323), Thomas M. Moriarty (Sold 215 577 shares of value $16 405 675 ), Troyen A. Brennan (Option Excercise at a value of $8 138 534), Troyen A. Brennan (Sold 135 925 shares of value $11 022 740 )